Erin D. Michos
Professor of Medicine
Also affiliated: University of Vermont (2016); Northwestern University (2013–2020); Twitter (United States) (2020–2022); University of Iowa (2013); American Heart Association (2007); Baptist Hospital of Miami (2017); Houston Methodist (2017–2020); National Institutes of Health (2013–2014); Michael E. DeBakey VA Medical Center (2017–2020); Albert Einstein College of Medicine (2008); Bloomberg (United States) (2018); University of Minnesota (2015–2017); Memorial Hermann (2025); Saint Agnes Hospital (2020); Apple (Israel) (2015); Cleveland Clinic (2015–2022); Mayo Clinic (2021); The University of Texas MD Anderson Cancer Center (2016); University of Wisconsin–Madison (2013–2016); University of Kentucky (2023); Johns Hopkins University (2005–2026); Emory University (2017–2020); Bayer (United States) (2023); Medical University of South Carolina (2017); University of Idaho (2016); University of Cape Town (2022); University of California, Los Angeles (2013); Oregon Health & Science University (2024); Illinois College (2015); The Lundquist Institute (2016); Baylor College of Medicine (2017–2020); East Carolina University (2020); Ollscoil na Gaillimhe – University of Galway (2019); School of the Art Institute of Chicago (2020); University of Washington (2014–2016); University of California, Irvine (2023); Montana State University (2016); Esperion Therapeutics (United States) (2022); Cardiovascular Institute of the South (2017); University of Michigan (2012); Johns Hopkins Medicine (2005–2026); Veterans Health Administration (2017); Hospital Israelita Albert Einstein (2012); Royal Stoke University Hospital (2019–2022); Association of Chartered Certified Accountants (2019); Welch Foundation (2021); McGill University Health Centre (2013–2015); University of Washington Medical Center (2014); WinnMed (2021); Johns Hopkins Bayview Medical Center (2020–2021); University Medical Center (2020); Johns Hopkins University Applied Physics Laboratory (2023); Henry Ford Hospital (2019); University of Mississippi Medical Center (2017); University of Alabama at Birmingham (2010–2017); Yale University (2024); Osun State University (2022); University of California San Diego (2008–2016); Clark Art Institute (2023); Novem (Netherlands) (2016); Novartis (China) (2023); General Department of Preventive Medicine (2020); Southwestern Medical Center (2023); Baptist Health South Florida (2017); VA San Diego Healthcare System (2016); University Hospital of Geneva (2013); Lahey Medical Center (2022); National Heart Lung and Blood Institute (2014–2015); Rochester General Hospital (2021–2023); AstraZeneca (Brazil) (2023); CGH Medical Center (2015); Boehringer Ingelheim (India) (2023); Medical University of Lodz (2015); Mayo Clinic in Arizona (2020); Daiseung Medics (South Korea) (2022); Minnesota Department of Health (2015); Berkeley Public Health Division (2012); Wisconsin Division of Public Health (2013); Johns Hopkins Hospital (2008–2025); National Institutes of Health Clinical Center (2016); Sidney Kimmel Comprehensive Cancer Center (2023); October 6 University (2016); Gramercy Research Group (United States) (2012); Southwestern Medical Center (2023); Wake Forest University (2010–2023); Keele University (2019–2021); University of Baltimore (2014–2025); Drexel University (2012); Columbia University (2010–2013); University of Pennsylvania (2013); The University of Texas Southwestern Medical Center (2023); American Congress of Obstetricians and Gynecologists (2007); Semtech (Canada) (2015); Vanderbilt University Medical Center (2024); Northeast Ohio Medical University (2017); University of California, Berkeley (2012); Stanford University (2017); Icahn School of Medicine at Mount Sinai (2008–2010)
Faculty Researcher
Biomedical Subjects
Links
Biography and Research Information
Metrics
- h-index: 104
- Publications: 1156
- Citations: 61,403
Selected Publications
-
Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial (2025)
-
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association (2025)
-
Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association (2024)
-
Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association (2024)
-
High lipoprotein(a): Actionable strategies for risk assessment and mitigation (2024)
-
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice (2024)
-
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association (2024)
-
Sex-specific differences in cardiovascular risk factors and implications for cardiovascular disease prevention in women (2023)
-
Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society (2023)
-
Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients (2023)
-
Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity (2023)
-
Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum (2023)
-
Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection (2023)
-
A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now? (2023)
-
Sleep Irregularity and Subclinical Markers of Cardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis (2023)
Collaboration Network
Top Collaborators
- Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
- Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta‐Analysis
- A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?
- Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement
- Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes
Showing 5 of 8 shared publications
- Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study
- Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis
- A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice
- Ten things to know about ten cardiovascular disease risk factors
- Development and Validation of Machine Learning–Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis
Showing 5 of 7 shared publications
- Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
- 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
- 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
- Psychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart Association
- Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association
Showing 5 of 6 shared publications
- Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis
- Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta‐Analysis
- Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials
- Gender disparities in difficulty accessing healthcare and cost-related medication non-adherence: The CDC behavioral risk factor surveillance system (BRFSS) survey
- Meta-analysis of effect of vegetarian diet on ischemic heart disease and all-cause mortality
- Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement
- A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice
- Ten things to know about ten cardiovascular disease risk factors
- Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement
- Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society For Preventive Cardiology Clinical Practice Statement
- Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study
- Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis
- Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels
- Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society For Preventive Cardiology Clinical Practice Statement
- Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients
- 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
- 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
- Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study
- Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels
- Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients
- Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis
- Ten things to know about ten cardiovascular disease risk factors
- Family income and cardiovascular disease risk in American adults
- Gender disparities in difficulty accessing healthcare and cost-related medication non-adherence: The CDC behavioral risk factor surveillance system (BRFSS) survey
- Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis
- Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta‐Analysis
- Causes of hospitalization in the USA between 2005 and 2018
- Meta-analysis of effect of vegetarian diet on ischemic heart disease and all-cause mortality
- KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
- Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence
- Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update
- DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases
- Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
- 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
- 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
- Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association
- Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
- 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
- 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
- Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association
- KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
- Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence
- Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update
- Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection
- Development and Validation of Machine Learning–Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis
- Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases
- DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases
- Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement
- Association of Carotid Artery Plaque With Cardiovascular Events and Incident Coronary Artery Calcium in Individuals With Absent Coronary Calcification
- DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases